[go: up one dir, main page]

AU1025199A - Coated medical implants, method for producing them, and use of the same for preventing restenosis - Google Patents

Coated medical implants, method for producing them, and use of the same for preventing restenosis

Info

Publication number
AU1025199A
AU1025199A AU10251/99A AU1025199A AU1025199A AU 1025199 A AU1025199 A AU 1025199A AU 10251/99 A AU10251/99 A AU 10251/99A AU 1025199 A AU1025199 A AU 1025199A AU 1025199 A AU1025199 A AU 1025199A
Authority
AU
Australia
Prior art keywords
producing
same
medical implants
coated medical
preventing restenosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10251/99A
Inventor
Werner Krause
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU1025199A publication Critical patent/AU1025199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D175/00—Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
    • C09D175/04—Polyurethanes
    • C09D175/08—Polyurethanes from polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
AU10251/99A 1997-09-29 1998-09-24 Coated medical implants, method for producing them, and use of the same for preventing restenosis Abandoned AU1025199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19744135A DE19744135C1 (en) 1997-09-29 1997-09-29 Medical implants coated with epothilone
DE19744135 1997-09-29
PCT/EP1998/006019 WO1999016416A2 (en) 1997-09-29 1998-09-24 Coated medical implants, method for producing them, and use of the same for preventing restenosis

Publications (1)

Publication Number Publication Date
AU1025199A true AU1025199A (en) 1999-04-23

Family

ID=7844759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10251/99A Abandoned AU1025199A (en) 1997-09-29 1998-09-24 Coated medical implants, method for producing them, and use of the same for preventing restenosis

Country Status (5)

Country Link
EP (1) EP1024842A2 (en)
JP (1) JP2001517543A (en)
AU (1) AU1025199A (en)
DE (1) DE19744135C1 (en)
WO (1) WO1999016416A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0977563B1 (en) 1996-12-03 2005-10-12 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6380394B1 (en) 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
AU4941400A (en) * 1999-05-27 2001-01-22 Biocompatibles Limited Local drug delivery
EP1274471B1 (en) 2000-04-11 2007-01-03 Polyzenix GmbH Use of Poly-tri-fluoro-ethoxypolyphosphazene for covering medical devices
EP1179353A1 (en) * 2000-08-11 2002-02-13 B. Braun Melsungen Ag Antithrombogenic implants with coating of polyphosphazenes and a pharmacologically active agent
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
DE10100961B4 (en) 2001-01-11 2005-08-04 Polyzenix Gmbh Body-compatible material and substrate coated with this material for the cultivation of cells and artificial organic implants constructed or grown from cells
DE10107795B4 (en) * 2001-02-13 2014-05-15 Berlex Ag Vascular support with a basic body, method for producing the vascular support, apparatus for coating the vascular support
BR0207321A (en) 2001-02-16 2004-02-10 Jomed Gmbh Fk506 Implants
EP1270026A1 (en) * 2001-06-22 2003-01-02 Erik Andersen Stents comprising vitamin D analogues for restenosis inhibition
ATE340551T1 (en) 2001-08-17 2006-10-15 Polyzenix Gmbh DEVICE BASED ON NITINOL WITH POLYPHOSPHAZENE COVER
DE10142881A1 (en) * 2001-09-03 2003-04-03 Jomed Gmbh Implant containing combretastatin A-4, useful for inhibiting growth of muscle cells, particularly prevention of restenosis, especially a stent or stent-graft
DK1483251T3 (en) 2002-03-12 2010-04-12 Bristol Myers Squibb Co C3-cyano-epothilone derivatives
DE10231336A1 (en) * 2002-07-11 2004-01-22 Bayer Ag stents
EP1767535B1 (en) 2002-08-23 2009-12-02 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
BR0317150A (en) * 2002-12-09 2005-11-01 Novartis Ag Stent microtubule stabilizers for the treatment of stenosis
US8318235B2 (en) 2003-01-22 2012-11-27 Cordis Corporation Method for applying drug coating to a medical device in surgeon room
US20050038504A1 (en) * 2003-01-22 2005-02-17 Harry Halleriet Kit for applying drug coating to a medical device in surgeon room
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20060121511A1 (en) 2004-11-30 2006-06-08 Hyerim Lee Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
ES2378905T3 (en) 2006-10-10 2012-04-19 Celonova Biosciences, Inc. Bioprotics heart valve with polyphosphazene
EP2065054A1 (en) * 2007-11-29 2009-06-03 Bayer Schering Pharma Aktiengesellschaft Combinations comprising a prostaglandin and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524451A1 (en) * 1985-07-09 1987-03-12 Behringwerke Ag Article for use in immunoassay coated with polymer
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3879031T2 (en) * 1987-08-08 1993-06-24 Akzo Nv CONCEPTUAL IMPLANT.
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
WO1993007217A1 (en) * 1991-10-01 1993-04-15 Otsuka Pharmaceutical Factory, Inc. Antithrombotic resin, tube, film and coating
US5599352A (en) * 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
US5342348A (en) * 1992-12-04 1994-08-30 Kaplan Aaron V Method and device for treating and enlarging body lumens
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
DE69403966T3 (en) * 1993-07-19 2008-04-17 Angiotech Pharmaceuticals, Inc., Vancouver ANTI-ANGIOGENIC AGENTS AND METHODS FOR THEIR USE
DE4334272C2 (en) * 1993-10-07 1996-07-18 Stemberger Axel Dr Coating for biomaterial and its use
EP0932399B1 (en) * 1996-03-12 2006-01-04 PG-TXL Company, L.P. Water soluble paclitaxel prodrugs
EP1616563A3 (en) * 1996-05-24 2006-01-25 Angiotech Pharmaceuticals, Inc. Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases

Also Published As

Publication number Publication date
WO1999016416A2 (en) 1999-04-08
WO1999016416A3 (en) 1999-08-05
EP1024842A2 (en) 2000-08-09
DE19744135C1 (en) 1999-03-25
JP2001517543A (en) 2001-10-09

Similar Documents

Publication Publication Date Title
AU1025199A (en) Coated medical implants, method for producing them, and use of the same for preventing restenosis
AU9091598A (en) Coated ophthalmic and implantable devices and methods for producing same
AU7091900A (en) Coating having biological activity and medical implant having surface carrying the same and method
AU3955795A (en) Biocompatible coating, medical device using the same and methods
AU4094199A (en) Radioactive intraluminal endovascular prosthesis and method for the treatment ofaneurysms
AU1053199A (en) Exposure apparatus and method of manufacturing the same, and exposure method
AU1684595A (en) Biocompatible implants
AU5095196A (en) Medical implants
AU1273201A (en) Biocompatible coated implant
AU1808197A (en) Medical stents, apparatus and method for making same
AU2377300A (en) Self-expanding prosthesis with biocompatible coating
AU694822B2 (en) Biocompatible medical lead
EP0623687A3 (en) Porous coated implant and method of making same.
AU7133298A (en) Implantable medical device and method of manufacture
AU6423796A (en) Bone prosthesis with protected coating for penetrating bone intergrowth
AU6169998A (en) Biocompatible polymers and methods for their use
AU7287998A (en) Bioabsorbable intermedullary implant systems and methods of use
HU9802422D0 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use
AU7601398A (en) Customized dental abutements and methods of preparing or selecting the same
AU2390695A (en) Placement of endoprostheses and stents
AU5517399A (en) Coated medical devices and implants
AU3031899A (en) Nanoparticles, method for producing nanoparticles and use of the same
AU6457398A (en) Odorizer or freshener article and method of making the same
AU2441100A (en) Highly scratch-resistant multilayer coat, method for producing and use of the same
AU9016898A (en) Methods and compositions for treatment of restenosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase